Patent ID: 9592002
Date: 2017-03-14
CPC Classifications: A61B,G16H

Claim:
1. A system for management of diabetes of a subject, the system comprising: at least one glucose monitor that is configured to measure a glucose concentration based on an enzymatic reaction with physiological fluid in a biosensor that provides an electrical signal representative of the glucose concentration; and a controller in communication with the at least one glucose monitor, the controller being configured to receive or transmit glucose data representative of glucose levels measured by the glucose monitor over a predetermined time period and to determine whether the glucose data includes or does not include: the controller, upon determination of the glucose data including both of the overall trend and minor trend but not the significant trend, annunciating to the subject such determination and using both of the determined overall trend and minor trend to calculate an amount of a drug to be delivered to the subject; and a drug delivery device in communication with the controller, the drug delivery device being configured to deliver the calculated amount of the drug to the subject.